Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An ionising radiation emitter is any source that emits ionising radiation, including electromagnetic waves (X-rays, gamma rays) and subatomic particles (alpha, beta, neutrons). These emissions have sufficient energy to ionize atoms and molecules by removing electrons, leading to potential biological damage. Sources can be natural (cosmic rays, radioactive isotopes) or artificial (X-ray tubes, nuclear reactors). Applications range from medical imaging and cancer therapy to industrial uses. Exposure poses health risks, including cancer and genetic mutations, necessitating strict safety protocols.
Ionising radiation interacts with matter, causing ionization by removing electrons from atoms. This energy deposition can lead to DNA damage, cell death, and tissue injury. Radioprotectors reduce damage through free radical scavenging. Radiosensitizers enhance radiation effects, particularly in cancer cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ionising Radiation Emitter.